For: | Bioulac-Sage P, Blanc JF, Rebouissou S, Balabaud C, Zucman-Rossi J. Genotype phenotype classification of hepatocellular adenoma. World J Gastroenterol 2007; 13(19): 2649-2654 [PMID: 17569132 DOI: 10.3748/wjg.v13.i19.2649] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v13/i19/2649.htm |
Number | Citing Articles |
1 |
Sarah Poetter-Lang, Ahmed Ba-Ssalamah, Nina Bastati, Sami A Ba-Ssalamah, Jacqueline C Hodge, Giuseppe Brancatelli, Valérie Paradis, Valérie Vilgrain. Hepatocellular adenoma update: diagnosis, molecular classification, and clinical course. British Journal of Radiology 2024; 97(1163): 1740 doi: 10.1093/bjr/tqae180
|
2 |
A E Obaro, S M Ryan. Benign liver lesions: grey-scale and contrast-enhanced ultrasound appearances. Ultrasound 2015; 23(2): 116 doi: 10.1177/1742271X15575805
|
3 |
Yang Shin Park, Chang Hee Lee, Jeong Woo Kim, Sora Shin, Cheol Min Park. Differentiation of hepatocellular carcinoma from its various mimickers in liver magnetic resonance imaging: What are the tips when using hepatocyte-specific agents?. World Journal of Gastroenterology 2016; 22(1): 284-299 doi: 10.3748/wjg.v22.i1.284
|
4 |
Luigi Grazioli, Maria Pia Bondioni, Hiroki Haradome, Utaroh Motosugi, Rita Tinti, Barbara Frittoli, Sebastiana Gambarini, Francesco Donato, Stefano Colagrande. Hepatocellular Adenoma and Focal Nodular Hyperplasia: Value of Gadoxetic Acid–enhanced MR Imaging in Differential Diagnosis. Radiology 2012; 262(2): 520 doi: 10.1148/radiol.11101742
|
5 |
Paulo Herman, Gilton Marques Fonseca, Jaime Arthur Pirola Kruger, Vagner Birk Jeismann, Fabricio Ferreira Coelho. Guidelines for the Treatment of Hepatocellular Adenoma in the Era of Molecular Biology: An Experience-Based Surgeons’ Perspective. Journal of Gastrointestinal Surgery 2021; 25(6): 1494 doi: 10.1007/s11605-020-04724-1
|
6 |
Taofic Mounajjed. Hepatocellular Adenoma and Focal Nodular Hyperplasia. Clinical Liver Disease 2021; 17(4): 244 doi: 10.1002/cld.1069
|
7 |
Timo Alexander Auer, Thula Walter-Rittel, Dominik Geisel, Wenzel Schöning, Moritz Schmelzle, Tobias Müller, Bruno Sinn, Timm Denecke, Bernd Hamm, Uli Fehrenbach. HBP-enhancing hepatocellular adenomas and how to discriminate them from FNH in Gd-EOB MRI. BMC Medical Imaging 2021; 21(1) doi: 10.1186/s12880-021-00552-0
|
8 |
Jimin Xu, Sebastiano Filetti, Jerome M. Hershman. Expression of Hepatocyte Nuclear Factor-1α mRNA in Human Anaplastic Thyroid Cancer Cell Lines and Tumors. Thyroid 2008; 18(5): 533 doi: 10.1089/thy.2007.0312
|
9 |
Jay H. Lefkowitch. Scheuer's Liver Biopsy Interpretation. 2010; : 181 doi: 10.1016/B978-0-7020-3410-7.00017-4
|
10 |
Roger Klein Moreira, Kay Washington. Gastrointestinal and Liver Pathology. 2012; : 626 doi: 10.1016/B978-1-4377-0925-4.00029-8
|
11 |
|
12 |
Linda D. Ferrell, Sanjay Kakar, Luigi M. Terracciano, Aileen Wee. MacSween's Pathology of the Liver. 2024; : 842 doi: 10.1016/B978-0-7020-8228-3.00013-2
|
13 |
Kwun Wah Wen, Sanjay Kakar. Hepatic Precancerous Lesions and Early Hepatocellular Carcinoma. Gastroenterology Clinics of North America 2024; 53(1): 109 doi: 10.1016/j.gtc.2023.11.005
|
14 |
V.J. Desmet, Juan Rosai. Rosai and Ackerman's Surgical Pathology. 2011; : 857 doi: 10.1016/B978-0-323-06969-4.00001-5
|
15 |
Tatsuaki Sumiyoshi, Michihisa Moriguchi, Hideyuki Kanemoto, Kouiku Asakura, Keiko Sasaki, Teiichi Sugiura, Takashi Mizuno, Katsuhiko Uesaka. Liver-specific contrast agent-enhanced magnetic resonance and 18F-fluorodeoxyglucose positron emission tomography findings of hepatocellular adenoma: report of a case. Surgery Today 2012; 42(2): 200 doi: 10.1007/s00595-011-0067-7
|
16 |
Regina Cheuk-Lam Lo, Irene Oi-Lin Ng. Hepatocellular tumors: Immunohistochemical analyses for classification and prognostication. Chinese Journal of Cancer Research 2011; 23(4): 245 doi: 10.1007/s11670-011-0245-6
|
17 |
Linda D. Ferrell, Sanjay Kakar, Luigi M. Terracciano, Aileen Wee. Macsween's Pathology of the Liver. 2018; : 780 doi: 10.1016/B978-0-7020-6697-9.00013-3
|
18 |
Inge J.S.M.L. Vanhooymissen, Maarten G. Thomeer, Loes M.M. Braun, Bibiche Gest, Sebastiaan van Koeverden, Francois E. Willemssen, Myriam Hunink, Robert A. De Man, Jan N. Ijzermans, Roy S. Dwarkasing. Intrapatient Comparison of the Hepatobiliary Phase of Gd‐BOPTA and Gd‐EOB‐DTPA in the Differentiation of Hepatocellular Adenoma From Focal Nodular Hyperplasia. Journal of Magnetic Resonance Imaging 2019; 49(3): 700 doi: 10.1002/jmri.26227
|
19 |
Oren Shaked, Evan S. Siegelman, Kim Olthoff, K. Rajender Reddy. Biologic and Clinical Features of Benign Solid and Cystic Lesions of the Liver. Clinical Gastroenterology and Hepatology 2011; 9(7): 547 doi: 10.1016/j.cgh.2011.03.007
|
20 |
Jianxin Yang, Xue Bai, Guiqin Liu, Xiangyang Li. A transcriptional regulatory network of HNF4α and HNF1α involved in human diseases and drug metabolism. Drug Metabolism Reviews 2022; 54(4): 361 doi: 10.1080/03602532.2022.2103146
|
21 |
Jay H. Lefkowitch. Recent developments in liver pathology. Human Pathology 2009; 40(4): 445 doi: 10.1016/j.humpath.2008.12.014
|
22 |
Jason You, Hushan Yang, Yinzhi Lai, Lindsay Simon, Jen Au, Ashlie L. Burkart. Erratum to ARID2, p110α, p53, and β-catenin protein expression in hepatocellular carcinoma and clinicopathologic implications. Human Pathology 2015; 46(7): 1068 doi: 10.1016/j.humpath.2015.05.005
|
23 |
Yongjun Liu, Yao-Zhong Liu, Lifu Sun, Yoh Zen, Chie Inomoto, Matthew M. Yeh. Subtyping of hepatocellular adenoma: a machine learning-based approach. Virchows Archiv 2022; 481(1): 49 doi: 10.1007/s00428-022-03311-w
|
24 |
Ulrike A. Köhler, Friederike Böhm, Frank Rolfs, Michèle Egger, Thorsten Hornemann, Manolis Pasparakis, Achim Weber, Sabine Werner. NF-κB/RelA and Nrf2 cooperate to maintain hepatocyte integrity and to prevent development of hepatocellular adenoma. Journal of Hepatology 2016; 64(1): 94 doi: 10.1016/j.jhep.2015.08.033
|
25 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 443 doi: 10.1007/978-3-319-26956-6_24
|
26 |
Taofic Mounajjed, Saba Yasir, Patrice A Aleff, Michael S Torbenson. Pigmented hepatocellular adenomas have a high risk of atypia and malignancy. Modern Pathology 2015; 28(9): 1265 doi: 10.1038/modpathol.2015.83
|
27 |
Marion Roux, Frederic Pigneur, Laurence Baranes, Julien Calderaro, Mélanie Chiaradia, Thomas Decaens, Sandrine Kastahian, Anaïs Charles-Nelson, Lambros Tselikas, Charlotte Costentin, Alexis Laurent, Daniel Azoulay, Ariane Mallat, Alain Rahmouni, Alain Luciani. Differentiating focal nodular hyperplasia from hepatocellular adenoma: Is hepatobiliary phase MRI (HBP-MRI) using linear gadolinium chelates always useful?. Abdominal Radiology 2018; 43(7): 1670 doi: 10.1007/s00261-017-1377-z
|
28 |
Nafis Shafizadeh, Sanjay Kakar. Diagnosis of Well-differentiated Hepatocellular Lesions. Advances in Anatomic Pathology 2011; 18(6): 438 doi: 10.1097/PAP.0b013e318234abb4
|
29 |
Timm Denecke, Ingo G. Steffen, Sheela Agarwal, Daniel Seehofer, Thomas Kröncke, Enrique Lopez Hänninen, Incken-Birthe Kramme, Peter Neuhaus, Sanjay Saini, Bernd Hamm, Christian Grieser. Appearance of hepatocellular adenomas on gadoxetic acid-enhanced MRI. European Radiology 2012; 22(8): 1769 doi: 10.1007/s00330-012-2422-5
|
30 |
Dimitrios Dimitroulis, Panagiotis Lainas, Petros Charalampoudis, Theodore Karatzas, Ioanna Delladetsima, Stratigoula Sakellariou, Nikolaos Karidis, Gregory Kouraklis. Co-existence of hepatocellular adenoma and focal nodular hyperplasia in a young female. World Journal of Hepatology 2012; 4(11): 314-318 doi: 10.4254/wjh.v4.i11.314
|
31 |
Paulo Herman, Fabricio Ferreira Coelho, Marcos Vinicius Perini, Renato Micelli Lupinacci, Luiz Augusto Carneiro D'Albuquerque, Ivan Cecconello. Hepatocellular adenoma: an excellent indication for laparoscopic liver resection. HPB 2012; 14(6): 390 doi: 10.1111/j.1477-2574.2012.00463.x
|
32 |
Melissa E. Kahn, Samuel French, Hanlin L. Wang. Hepatocellular Adenoma. Pathology Case Reviews 2009; 14(1): 13 doi: 10.1097/PCR.0b013e31819c4956
|
33 |
Elaine S. Chan, Matthew M. Yeh. The Use of Immunohistochemistry in Liver Tumors. Clinics in Liver Disease 2010; 14(4): 687 doi: 10.1016/j.cld.2010.10.001
|
34 |
Jan H.M.B. Stoot, Robert J.S. Coelen, Mechteld C. De Jong, Cornelis H.C. Dejong. Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases. HPB 2010; 12(8): 509 doi: 10.1111/j.1477-2574.2010.00222.x
|
35 |
Dirk Schmidt-Arras, Miryam Müller, Marija Stevanovic, Silke Horn, Antje Schütt, Juri Bergmann, Ruven Wilkens, Annett Lickert, Stefan Rose-John. Oncogenic deletion mutants of gp130 signal from intracellular compartments. Journal of Cell Science 2013; doi: 10.1242/jcs.130294
|
36 |
Aurélie Beaufrère, Valérie Paradis. Hepatocellular adenomas: review of pathological and molecular features. Human Pathology 2021; 112: 128 doi: 10.1016/j.humpath.2020.11.016
|
37 |
Hengqi (Betty) Zheng, Laura S. Finn, Karen F. Murray. Pediatric Gastrointestinal and Liver Disease. 2021; : 527 doi: 10.1016/B978-0-323-67293-1.00048-7
|
38 |
Elia Pulvirenti, Adriana Toro, Isidoro Di Carlo. An Update on Indications for Treatment of Solid Hepatic Neoplasms in Noncirrhotic Liver. Future Oncology 2010; 6(8): 1243 doi: 10.2217/fon.10.85
|
39 |
Luigi Grazioli, Lucio Olivetti, Giancarlo Mazza, Maria Pia Bondioni. MR Imaging of Hepatocellular Adenomas and Differential Diagnosis Dilemma. International Journal of Hepatology 2013; 2013: 1 doi: 10.1155/2013/374170
|
40 |
Jay H. Lefkowitch. Scheuer's Liver Biopsy Interpretation. 2016; : 193 doi: 10.1016/B978-0-7020-5548-5.00011-6
|
41 |
Jean–Charles Nault, Paulette Bioulac–Sage, Jessica Zucman–Rossi. Hepatocellular Benign Tumors—From Molecular Classification to Personalized Clinical Care. Gastroenterology 2013; 144(5): 888 doi: 10.1053/j.gastro.2013.02.032
|
42 |
Christopher O C Bellamy, R Scott Maxwell, Sandrine Prost, Ijeoma A Azodo, James J Powell, Jonathan R Manning. The value of immunophenotyping hepatocellular adenomas: consecutive resections at one UK centre. Histopathology 2013; 62(3): 431 doi: 10.1111/his.12011
|
43 |
Thomas Longerich, Volker Endris, Olaf Neumann, Eugen Rempel, Martina Kirchner, Zahra Abadi, Sebastian Uhrig, Mark Kriegsmann, Karl Heinz Weiss, Kai Breuhahn, Arianeb Mehrabi, Tim Frederik Weber, Ludwig Wilkens, Beate K Straub, Andreas Rosenwald, Falko Schulze, Benedikt Brors, Stefan Froehling, Rossella Pellegrino, Jan Budczies, Peter Schirmacher, Albrecht Stenzinger. RSPO2 gene rearrangement: a powerful driver of β-catenin activation in liver tumours. Gut 2019; 68(7): 1287 doi: 10.1136/gutjnl-2018-317632
|
44 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_24-1
|
45 |
Julien Calderaro, Jessica Zucman‐Rossi. Schiff's Diseases of the Liver. 2017; : 947 doi: 10.1002/9781119251316.ch35
|
46 |
Matthanja Bieze, Roelof J. Bennink, Youssef El-Massoudi, Saffire S.K.S. Phoa, Joanne Verheij, Ulrich Beuers, Thomas M. van Gulik. The use of 18F-fluoromethylcholine PET/CT in differentiating focal nodular hyperplasia from hepatocellular adenoma. Nuclear Medicine Communications 2013; 34(2): 146 doi: 10.1097/MNM.0b013e32835afe62
|
47 |
Jianhong Li, Zongming Eric Chen, Fan Lin. Handbook of Practical Immunohistochemistry. 2022; : 661 doi: 10.1007/978-3-030-83328-2_27
|
48 |
Zongming E. Chen, Jeffrey Prichard, Fan Lin. Handbook of Practical Immunohistochemistry. 2015; : 503 doi: 10.1007/978-1-4939-1578-1_26
|
49 |
Geunyoung Jung, Yongjun Liu. Hepatocellular Adenoma: A Case Report, Current Updates on Subtyping, and Diagnostic Pitfalls. AJSP: Reviews and Reports 2022; 27(6): 228 doi: 10.1097/PCR.0000000000000527
|
50 |
|
51 |
Tetsuyuki Takahashi, Takeshi Nishida, Hayato Baba, Hideki Hatta, Johji Imura, Mitsuko Sutoh, Syunji Toyohara, Ryoji Hokao, Syunsuke Watanabe, Hirohisa Ogawa, Hisanori Uehara, Koichi Tsuneyama. Histopathological characteristics of glutamine synthetase-positive hepatic tumor lesions in a mouse model of spontaneous metabolic syndrome (TSOD mouse). Molecular and Clinical Oncology 2016; 5(2): 267 doi: 10.3892/mco.2016.924
|
52 |
Anne-Frédérique Manichon, Brigitte Bancel, Marion Durieux-Millon, Christian Ducerf, Jean-Yves Mabrut, Marie-Annick Lepogam, Agnès Rode. Hepatocellular Adenoma: Evaluation with Contrast-Enhanced Ultrasound and MRI and Correlation with Pathologic and Phenotypic Classification in 26 Lesions. HPB Surgery 2012; 2012: 1 doi: 10.1155/2012/418745
|
53 |
Madhavi Patnana, Christine O. Menias, Perry J. Pickhardt, Mohamed Elshikh, Sanaz Javadi, Ayman Gaballah, Akram M. Shaaban, Brinda Rao Korivi, Naveen Garg, Khaled M. Elsayes. Liver Calcifications and Calcified Liver Masses: Pattern Recognition Approach on CT. American Journal of Roentgenology 2018; 211(1): 76 doi: 10.2214/AJR.18.19704
|
54 |
Matthanja Bieze, Paulette Bioulac-Sage, Joanne Verheij, Charles Balabaud, Christophe Laurent, Thomas M. van Gulik. Hepatocellular Adenomas Associated with Hepatic Granulomas: Experience in Five Cases. Case Reports in Gastroenterology 2012; 6(3): 677 doi: 10.1159/000343434
|
55 |
Maneesh Khanna, Subramaniyan Ramanathan, Najla Fasih, Nicola Schieda, Vivek Virmani, Matthew D. F. McInnes. Current updates on the molecular genetics and magnetic resonance imaging of focal nodular hyperplasia and hepatocellular adenoma. Insights into Imaging 2015; 6(3): 347 doi: 10.1007/s13244-015-0399-8
|
56 |
Gillian Hale, Xinxin Liu, Junjie Hu, Zhong Xu, Li Che, David Solomon, Christos Tsokos, Nafis Shafizadeh, Xin Chen, Ryan Gill, Sanjay Kakar. Correlation of exon 3 β-catenin mutations with glutamine synthetase staining patterns in hepatocellular adenoma and hepatocellular carcinoma. Modern Pathology 2016; 29(11): 1370 doi: 10.1038/modpathol.2016.122
|
57 |
Janardhana Ponnatapura, Ania Kielar, Lauren M.B. Burke, Mark E. Lockhart, Abdul-Rahman Abualruz, Rafel Tappouni, Neeraj Lalwani. Hepatic complications of oral contraceptive pills and estrogen on MRI: Controversies and update - Adenoma and beyond. Magnetic Resonance Imaging 2019; 60: 110 doi: 10.1016/j.mri.2019.04.010
|
58 |
Timo Alexander Auer, Uli Fehrenbach, Christian Grieser, Tobias Penzkofer, Dominik Geisel, Moritz Schmelzle, Tobias Müller, Hendrik Bläker, Daniel Seehofer, Timm Denecke. Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation?. European Radiology 2020; 30(6): 3497 doi: 10.1007/s00330-020-06726-8
|
59 |
Sandra E. Fischer. Hepatocellular carcinoma arising in hepatic adenoma: diagnostic and management implications. Diagnostic Histopathology 2014; 20(6): 257 doi: 10.1016/j.mpdhp.2014.03.007
|
60 |
Joseph Misdraji, Barbara A. Centeno, Martha B. Pitman. Ancillary tests in the diagnosis of liver and pancreatic neoplasms. Cancer Cytopathology 2018; 126(S8): 672 doi: 10.1002/cncy.22009
|
61 |
Venkata S. Katabathina, Christine O. Menias, Alampady K. P. Shanbhogue, Jaishree Jagirdar, Raj Mohan Paspulati, Srinivasa R. Prasad. Genetics and Imaging of Hepatocellular Adenomas: 2011 Update. RadioGraphics 2011; 31(6): 1529 doi: 10.1148/rg.316115527
|
62 |
|
63 |
Mohammad Ali Husainy, Farhina Sayyed, Praveen Peddu. Typical and atypical benign liver lesions: A review. Clinical Imaging 2017; 44: 79 doi: 10.1016/j.clinimag.2017.05.002
|
64 |
Christian Grieser, Ingo G. Steffen, Incken-Birthe Kramme, Hendrik Bläker, Ergin Kilic, Carmen Maria Perez Fernandez, Daniel Seehofer, Eckart Schott, Bernd Hamm, Timm Denecke. Gadoxetic acid enhanced MRI for differentiation of FNH and HCA: a single centre experience. European Radiology 2014; 24(6): 1339 doi: 10.1007/s00330-014-3144-7
|
65 |
Jay H. Lefkowitch. Scheuer's Liver Biopsy Interpretation. 2021; : 205 doi: 10.1016/B978-0-7020-7584-1.00011-5
|
66 |
Nancy M. Joseph, Annika Blank, Alan H. Shain, Ryan M. Gill, Sarah E. Umetsu, Nafis Shafizadeh, Michael S. Torbenson, Sanjay Kakar. Hepatocellular neoplasms with loss of liver fatty acid binding protein: Clinicopathologic features and molecular profiling. Human Pathology 2022; 122: 60 doi: 10.1016/j.humpath.2022.01.007
|
67 |
Hyunchul Kim, Ja-June Jang, Dong-Sik Kim, Beom Woo Yeom, Nam Hee Won. Clinicopathological Analysis of Hepatocellular Adenoma According to New Bordeaux Classification: Report of Eight Korean Cases. Korean Journal of Pathology 2013; 47(5): 411 doi: 10.4132/KoreanJPathol.2013.47.5.411
|
68 |
Jean Charles Nault, Jessica Zucman Rossi. Molecular Classification of Hepatocellular Adenomas. International Journal of Hepatology 2013; 2013: 1 doi: 10.1155/2013/315947
|
69 |
Jason You, Hushan Yang, Yinzhi Lai, Lindsay Simon, Jen Au, Ashlie L. Burkart. AT-rich interactive domain 2, p110α, p53, and β-catenin protein expression in hepatocellular carcinoma and clinicopathologic implications. Human Pathology 2015; 46(4): 583 doi: 10.1016/j.humpath.2015.01.001
|
70 |
Hervé Laumonier, Paulette Bioulac-Sage, Christophe Laurent, Jessica Zucman-Rossi, Charles Balabaud, Hervé Trillaud. Hepatocellular adenomas: Magnetic resonance imaging features as a function of molecular pathological classification. Hepatology 2008; 48(3): 808 doi: 10.1002/hep.22417
|
71 |
Jeffrey Prichard, Fan Lin. Handbook of Practical Immunohistochemistry. 2011; : 389 doi: 10.1007/978-1-4419-8062-5_23
|
72 |
Antje Schütt, Martin Zacharias, Nico Schneider, Silke Horn, Joachim Grötzinger, Stefan Rose-John, Dirk Schmidt-Arras. gp130 activation is regulated by D2–D3 interdomain connectivity. Biochemical Journal 2013; 450(3): 487 doi: 10.1042/BJ20121660
|
73 |
Jing Han, Marius C. van den Heuvel, Hironori Kusano, Koert P. de Jong, Annette S. H. Gouw. How Normal Is the Liver in Which the Inflammatory Type Hepatocellular Adenoma Develops?. International Journal of Hepatology 2012; 2012: 1 doi: 10.1155/2012/805621
|
74 |
Hisafumi KITAGAWA, Shouiti TSUDA, Kaori TUBOI, Ken YAGI, Akira YAMAMOTO, Tatsuhiko KITAMURA, Hideaki ENZAN, Makoto TOI. A Case of Well-differentiated Hepatocellular Carcinoma that Developed in a Normal Liver of a Young Woman. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) 2014; 75(1): 190 doi: 10.3919/jjsa.75.190
|
75 |
Vishal S Chandan, Sejal S Shah, Taofic Mounajjed, Michael S Torbenson, Tsung-Teh Wu. Copper deposition in focal nodular hyperplasia and inflammatory hepatocellular adenoma. Journal of Clinical Pathology 2018; 71(6): 504 doi: 10.1136/jclinpath-2017-204820
|